Drug interaction study aims to improve COPD treatment safety
NCT ID NCT06892756
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This study looked at how cyclosporine, a drug that blocks certain transporters, changes the amount of CHF6001 in the blood. Thirty healthy adults took CHF6001 alone and then with cyclosporine to compare drug levels. The goal is to understand potential interactions and guide safe dosing for COPD patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical Centre Comac Medical Ltd
Sofia, 1612, Bulgaria
Conditions
Explore the condition pages connected to this study.